Matthew M. Gosling is CLO & VP at DEPOMED INC (DEPO). They have made 5 open-market trades across 1 company since 2009, most recently 2018-05-11.
CIK 0001367754
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DEPO | 19,674 | $144K |
Shares reported on the most recent Form 4, priced at the 2018-04-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DEPO | SELL | 2018-05-11 | 2018-05-15 | $7.07 | $278K | -14.6% | -6.1% | -3.2% |
| DEPO | SELL | 2018-03-07 | 2018-03-09 | $6.58 | $599K | -4.9% | -4.3% | -6.3% |
| DEPO | SELL | 2017-05-11 | 2017-05-15 | $11.37 | $1.3M | -11.9% | -17.4% | -48.1% |
| DEPO | SELL · 10b5-1 | 2014-12-02 | 2014-12-03 | $15.85 | $140K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL · 10b5-1 | 2014-11-19 | 2014-11-21 | $15.36 | $1.1M | -20.6% | +2.4% | +2.4% |
| DEPO | SELL | 2014-03-14 | 2014-03-14 | $14.74 | $322K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $8.40 | $48K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL · 10b5-1 | 2012-12-12 | 2012-12-14 | $5.84 | $384K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL · 10b5-1 | 2012-12-06 | 2012-12-06 | $5.80 | $15K | -20.6% | +2.4% | +2.4% |
| DEPO | SELL | 2009-08-11 | 2009-08-13 | $3.67 | $93K | -20.6% | +2.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.